SEARCH RESULTS FOR: "Tag: XBI"
REFINE YOUR SEARCH:
ARTICLES/BLOGS
2019(3)
2018(5)
2017(14)
2016(5)
2015(1)
CATEGORIES
5-Minute Market Rundown(1)
Bernie's Content(3)
Best and Worst Stocks(4)
By the Numbers(1)
Editor's Pick(1)
Expectational Analysis(1)
Indexes and ETFs(15)
Indicator of the Week(1)
Intraday Option Activity(11)
Quantitative Analysis(6)
Stock Market News(6)
Stocks On the Move(3)
Technical Analysis(2)
Unusual Trading Activity(1)

5/26/2019 8:34 AM
The following is a reprint of the market commentary from the June 2019 edition of The Option Advisor, published on May 24. For more information, or to subscribe to The Option Advisor -- featuring 10...
3/4/2019 9:44 AM
The technical breakout last week in the SPDR S&P Biotech ETF (XBI) was remarkable, by any number of measures. After a 3% opening gap to start Monday's session, the small-cap biotech-focused exchange-...
1/23/2019 2:46 PM
It's turning out to be a down day for drug stocks, as the SPDR S&P Biotech ETF (XBI) trades down 1.8% at $79.43. In the meantime, one options trader is putting their money behind a three-way bearish ...
11/6/2018 2:30 PM
Midterm elections are taking place across the U.S. today, as you're likely well aware. Last week, we took a broader look at the impact of these mid-cycle votes on stocks. This week, with expectations...
7/17/2018 7:34 AM
As we head into July options expiration week, there's no shortage of catalysts -- both micro and macro -- to drive major stock market moves. Not only are we heading into the thick of second-quarter ea...

Welcome to Schaeffer's Investment Research! We are a privately held provider of stock and options trading recommendations, options education, and market commentary, headquartered in Cincinnati, Ohio. Founded in 1981 by industry pioneer Bernie Schaeffer, we've since become a trusted source of research and analysis for individual investors and major financial media outlets alike.







Partner Center